ML210-ansaFc
ML210-ansaFc (Compound III-13) is a covalent GPX4 inhibitor with a [3]-ferrocenophane group (IC50 of 3.4 μM) . ML210-ansaFc potently induces ferroptosis by increasing the level of ROSand promoting lipid peroxidation (LPO) in cancers cells. ML210-ansaFc has an anticancer activity and suppresses tumor growth in tumor 3D spheroids. ML210-ansaFc can be used for cancer therapy resistance research[1].
Product Specifications
UNSPSC
12352100
Target
Ferroptosis; Glutathione Peroxidase; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C1=CSC(C#C)=N1)N2CCN(CC2)C(CCc3cccc3)c4cccc4.[][Fe][]
Molecular Formula
C23H23FeN3OS
Molecular Weight
445.36
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GPX4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Escherichia coli O157:H7 Ribokinase (rbsK)
Recombinant Escherichia coli O157:H7 Ribokinase (rbsK)
Recombinant Escherichia coli O157:H7 Ribokinase (rbsK)
Recombinant Escherichia coli O157:H7 Ribokinase (rbsK)
Recombinant Escherichia coli O157:H7 Ribokinase (rbsK)